In T cell lymphoma, Marzec et al [50] found that STAT3 upregulates PD-L1 expression by binding to the PD-L1 promoter; this effect can be suppressed by silencing STAT3 with siRNA. This evidence concerns the gene STAT3 and T-cell non-Hodgkin lymphoma.